Why the study?
Diagnosing myocarditis is challenging during the COVID-19 pandemic due to overlapping clinical presentations with Multisystem Inflammatory Syndrome in Children (MIS-C).
Highlights the clinical challenge of differentiating pediatric viral myocarditis from MIS-C in the COVID-19 era.
Diagnostic overlap with MIS-C warrants cautious myocarditis evaluation in children; leaves open refined pediatric criteria.
Myocarditis has a wide array of clinical presentations ranging from asymptomatic to sudden cardiac death. Pediatric myocarditis is a rare disease, with an estimated annual incidence of 1 to 2 per 100,000 children though its true prevalence remains unknown due to its variable and often subclinical presentation. The diagnosis of myocarditis is challenging in the era of COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C), which can have overlapping clinical conundrum. Here, we present a case of a 17-year-old male presenting with chest tightness, shortness of breath, and electrocardiogram (EKG) findings concerning for myocardial injury along with elevated inflammatory markers such as D-dimer, ESR (Erythrocyte Sedimentation Rate), and CRP (C-Reactive Protein). We discuss the key elements of our clinical experience with this case and review the literature for pediatric myocarditis, with a focus on differentiating it from MIS-C in the current COVID-19 pandemic era.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: